Prospective, Randomized, Placebo Controlled Trial of the Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Nitric oxide (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Sponsors Novoteris
- 03 Mar 2021 Status changed from recruiting to discontinued.
- 24 Feb 2020 Planned End Date changed from 31 Dec 2019 to 1 May 2020.
- 24 Feb 2020 Planned primary completion date changed from 31 Dec 2019 to 1 May 2020.